Aptamers to beta-NGF and their use in treating beta-NGF mediated diseases and disorders

Details for Australian Patent Application No. 2011240774 (hide)

Owner SomaLogic, Inc. Otsuka Pharmaceutical Co., Ltd.

Inventors Schneider, Daniel J.; Hisaminato, Akihiko; Waugh, Sheela; Resnicow, Daniel; Nagabukuro, Akira; Ono, Toshihide

Agent Davies Collison Cave

Pub. Number AU-A-2011240774

PCT Pub. Number WO2011/130195

Priority 61/323,145 12.04.10 US

Filing date 12 April 2011

Wipo publication date 20 October 2011

International Classifications

C12P 19/34 Preparation of compounds containing saccharide radicals

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/130195 Priority application(s): WO2011/130195

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011240776-Energy absorbing vehicle barrier

2011240773-Methods for producing viloxazine salts and novel polymorphs thereof